Medcross

The vendor opportunity at Medcross

Medcross is a health-services brand headquartered in Virginia with a single company-owned unit. For software vendors, this is not a volume play. The entire addressable market is one location. However, the unit's average unit volume (AUV) of $5,032,982 signals a substantial operation that likely requires robust, compliant software. The royalty rate is 7.5% of gross revenue, and the initial franchise term runs for 7 years. Year-over-year unit growth is not disclosed in the most recent FDD. Vendors evaluating Medcross should weigh the concentrated decision-making against the limited total contract value.

Who controls software purchasing

All purchasing authority rests with the headquarters. The 2025 FDD lists Homa Puga as President. In a system this small, there is no multi-unit operator layer or regional hierarchy to navigate. A vendor's sales process is a direct pitch to the President's office. There are no other named executives or operators on file. This centralization means a single relationship can unlock the entire system, but it also means there is no secondary path if that relationship stalls.

Mandated and current tech stack

Medcross mandates three specific systems: CollaborateMD, Kinnser ADL, and Qvinci. CollaborateMD is a practice management and medical billing platform. Kinnser ADL is a home health agency management solution. Qvinci provides financial reporting and consolidation. These mandates are disclosed in the FDD and represent the core operational stack. Any vendor selling into Medcross must either integrate with, complement, or displace one of these entrenched systems. The FDD does not list any recommended or optional technology beyond these three mandates.

Procurement, renewals, and timing

The FDD does not include an Item 8 procurement signal in our corpus, so the formal procurement model—whether designated supplier, approved supplier, or open—remains unknown. This lack of disclosure means vendors should clarify the process early in conversations. On renewals, Item 17 provides a conditional path: a franchisee in good standing can renew for up to two additional terms of 5 years each, unless the franchisor decides to withdraw from the territory. The initial term is 7 years. These timelines suggest potential reevaluation points at the 7-year and 12-year marks, though with only one unit, the franchisor may operate on an ad-hoc refresh cycle rather than a fleet-wide schedule.

How to read the Medcross FDD

The 2025 Medcross Franchise Disclosure Document is the primary source for all data points discussed here. It details the single-unit structure, the $5.0M AUV, the 7.5% royalty, and the mandated technology stack. For vendors, the FDD is a due diligence document, not a sales brochure. Focus on Item 11 (franchisor's obligations) for tech mandates, Item 17 (renewal) for contract windows, and Item 19 (financial performance) for the unit economics that shape a prospect's budget. The embedded viewer below provides the full filing. For a ranked target list of franchise systems that match your software, reach out to FranCloud.